Drug Products

-LifeViroTreat –A  Potential Remedy for covid-19 treatment.

Product NameLifeViroTreat.
Therapy TypeInhalation through nebulizer.
IndicationTreatment for COVID-19, It can also be explored for other flu, influenza and other virus respiratory disease.
Drug ClassificationNew Drug.
Drug SubstanceNon-pharmacopoeia.
Intellectual Property StatusPCT filing activity for pharmaceutical composition as an inhaler is completed in October 2020 with priority date April 2020. 
Future StrategyNew IP support filing will be explored.
Status of Drug at CDGI-India Phase-I trial is permitted and going to start by next week. 
Treatment duration Nebulise for 15 min every 4 hrs for 3 days.